The BSE shareholding data showed that IFC held 5.4 per cent stake in the company at the end of June.
By ET Bureau |
ThinkStock Photos
Investor Ashish Kacholia on Monday bought 20 lakh shares of pharmaceutical firm Hikal at Rs 166.5 per share.
MUMBAI: Investor Ashish Kacholia on Monday bought 20 lakh shares of pharmaceutical firm Hikal at Rs 166.5 per share, bulk deal data on the NSE showed. The data showed that International Finance Corportation (IFC) sold 39.82 lakh shares at Rs 166.5 per share. The BSE shareholding data showed that IFC held 5.4 per cent stake in the company at the end of June. The stock ended up 14.8 per cent at Rs 185.35 on the BSE on Monday.